(c) abstract and author debates or editorials
First, BPC-157 upregulates growth hormone receptor expression in tendon fibroblasts (Chang et al., 2014), thereby sensitizing the cells to circulating growth hormone and amplifying local repair signalling
BPC-157 is sold for research purposes and is not approved by Health Canada or the FDA for human therapeutic use
Already ordered my next months supply
For most skin and recovery research built around the GHK-Cu/BPC-157/TB-500 mechanisms, the GLOW base is the established formulation
It's particularly warranted if mood symptoms are accompanied by neurological signs (numbness, tingling, balance issues) or anemia symptoms (fatigue, pallor, shortness of breath)